These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1792310)

  • 1. Rationale for a quality assurance programme in clinical trials of conservative management of breast carcinoma. European Organization for the Research and Treatment of Cancer.
    Horiot JC
    Radiother Oncol; 1991 Dec; 22(4):222-5. PubMed ID: 1792310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period.
    Poortmans PM; Ataman F; Davis JB; Bartelink H; Horiot JC; Pierart M; Collette L; Van Tienhoven G
    Radiother Oncol; 2005 Sep; 76(3):278-84. PubMed ID: 15919127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance in conservative treatment of early breast cancer. Report on a consensus meeting of the EORTC Radiotherapy and Breast Cancer Cooperative Groups and the EUSOMA (European Society of Mastology).
    Bartelink H; Garavaglia G; Johansson KA; Mijnheer BJ; Van den Bogaert W; van Tienhoven G; Yarnold J
    Radiother Oncol; 1991 Dec; 22(4):323-6. PubMed ID: 1792330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview.
    van Tienhoven G; Mijnheer BJ; Bartelink H; González DG
    Strahlenther Onkol; 1997 Apr; 173(4):201-7. PubMed ID: 9111608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance of the EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": the Dummy Run. EORTC Radiotherapy Cooperative Group.
    van Tienhoven G; van Bree NA; Mijnheer BJ; Bartelink H
    Radiother Oncol; 1991 Dec; 22(4):290-8. PubMed ID: 1792323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Quality Assurance programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts.
    Kouloulias VE; Poortmans PM; Bernier J; Horiot JC; Johansson KA; Davis B; Godson F; Garavaglia G; Pierart M; van der Schueren E
    Eur J Cancer; 2003 Mar; 39(4):430-7. PubMed ID: 12751372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary--medial supraclavicular irradiation in stage I-III breast cancer: the individual case review.
    Poortmans P; Kouloulias VE; Venselaar JL; Struikmans H; Davis JB; Huyskens D; van Tienhoven G; Hurkmans C; Mijnheer B; Van den Bogaert W
    Eur J Cancer; 2003 Sep; 39(14):2035-42. PubMed ID: 12957458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial breast irradiation for early breast cancer.
    Lehman M; Hickey BE; Francis DP; See AM
    Cochrane Database Syst Rev; 2014 Jun; (6):CD007077. PubMed ID: 24938937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
    Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
    Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance.
    Mason MD; Moore R; Jones G; Lewis G; Donovan JL; Neal DE; Hamdy FC; Lane JA; Staffurth JN;
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e92-e100. PubMed ID: 27425582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of tangential field planning and dose distribution in the UK: background to the introduction of the quality assurance programme for the START trial in early breast cancer.
    Winfield EA; Deighton A; Venables K; Hoskin PJ; Aird EG;
    Br J Radiol; 2003 Apr; 76(904):254-9. PubMed ID: 12711645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control review for radiotherapy of small breast cancer: analysis of 708 patients in the GBSG I trial. German Breast Study Group (GBSG).
    Seegenschmiedt MH; Sauerbrei W; Sauer R; Schumacher M; Schauer A; Rauschecker HF; Dinkloh H; Dühmke E; Haase KD; Haase W
    Strahlenther Onkol; 1993 Jun; 169(6):339-50. PubMed ID: 8316938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I--III breast cancer(1).
    Poortmans PM; Venselaar JL; Struikmans H; Hurkmans CW; Davis JB; Huyskens D; van Tienhoven G; Vlaun V; Lagendijk JJ; Mijnheer BJ; De Winter KA; Van der Hulst MH; Van den Bogaert WF
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1399-408. PubMed ID: 11286848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assurance in conservative treatment of early breast cancer, a consensus meeting. December 13-14, 1990, Tübingen, Germany.
    Radiother Oncol; 1991 Dec; 22(4):219-338. PubMed ID: 1792309
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality assurance in radiotherapy.
    Kouloulias VE
    Eur J Cancer; 2003 Mar; 39(4):415-22. PubMed ID: 12751370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The programme of quality assurance of the EORTC radiotherapy group. A historical overview.
    Horiot JC; van der Schueren E; Johansson KA; Bernier J; Bartelink H
    Radiother Oncol; 1993 Nov; 29(2):81-4. PubMed ID: 8310157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EORTC-Breast Cancer Cooperative Group clinical research programme in early breast cancer. EORTC-BCCG.
    Piccart MJ; van de Velde CJ
    Recent Results Cancer Res; 1998; 152():447-52. PubMed ID: 9928579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European Organization for Research and Treatment for Cancer (EORTC) strategy for quality assurance in surgical clinical research: Assessment of the past and moving towards the future.
    Tanis E; Caballero C; Collette L; Verleye L; den Dulk M; Lacombe D; Schuhmacher C; Werutsky G
    Eur J Surg Oncol; 2016 Aug; 42(8):1115-22. PubMed ID: 27241924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.
    Thomas JS; Hanby AM; Russell N; van Tienhoven G; Riddle K; Anderson N; Cameron DA; Bartlett JM; Piper T; Cunningham C; Canney P; Kunkler IH;
    Breast Cancer Res Treat; 2017 May; 163(1):63-69. PubMed ID: 28190252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.
    Manyam BV; Tendulkar R; Cherian S; Vicini F; Badiyan SN; Shah C
    Am J Clin Oncol; 2018 Jun; 41(6):526-531. PubMed ID: 27635622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.